Alzheimer's drug trial halted early: what happened with PrimeC?
Disease control
Terminated
This study tested a drug called PrimeC in people with mild to moderate Alzheimer's disease. The goal was to see if it is safe and if it helps with thinking and daily activities. The trial was stopped early and only 8 people took part, so results are limited.
Phase: PHASE2 • Sponsor: NeuroSense Therapeutics Ltd. • Aim: Disease control
Last updated May 11, 2026 20:47 UTC